文献速递乳腺技术与安全US

二维超声与超声造影测量乳腺癌与良性肿瘤的大小差异

The Size Differences of Breast Cancer and Benign Tumors Measured by Two-Dimensional Ultrasound and Contrast-Enhanced Ultrasound.
PubMed 文献 · J Ultrasound Med · 2024-03-13

该研究纳入42例临床确诊乳腺癌和47例良性乳腺肿瘤,由两名有经验的医师分别用二维超声(2DUS)和超声造影(CEUS)独立测量肿块最大长径和横径。结果显示两种肿瘤CEUS测值均大于2DUS,且乳腺癌的增大程度较良性肿瘤更明显;以长径和横径的2DUS与CEUS差值鉴别乳腺癌与良性肿瘤的ROC曲线下面积分别为0.870和0.863。

要点

  • 乳腺癌CEUS较2DUS测值增大的幅度大于良性肿瘤,可作为鉴别参考。
  • 长径差值阈值0.215时敏感度0.842、特异度0.783,横径差值阈值0.203时敏感度0.667、特异度0.936。
  • CEUS可能提供更精确的肿瘤大小评估,作者认为对乳腺癌治疗决策有意义。

核心结论

  • 乳腺癌与良性肿瘤的CEUS测值均大于2DUS,且乳腺癌CEUS较2DUS的增大程度比良性肿瘤更明显;作者认为CEUS可能提供更精确的肿瘤大小评估。

研究设计与样本

  • 研究论文,纳入42例临床确诊乳腺癌和47例良性乳腺肿瘤,由两名有经验的医师独立在2DUS和CEUS上测量肿块最大长径和横径,分析使用R(4.2.2)和GraphPad Prism 6。

关键影像表现/征象

  • 乳腺癌CEUS最大长径较2DUS增大26.61±0.21%,最大横径较2DUS增大26.24±0.19%。
  • 良性乳腺肿瘤CEUS最大长径较2DUS增大11.74±0.21%,最大横径较2DUS增大11.06±0.14%。

诊断标准与关键数值

  • 以长径的2DUS与CEUS差值鉴别乳腺癌与良性肿瘤:AUC 0.870(95%CI 0.795-0.945),敏感度0.842,特异度0.783,阈值0.215。
  • 以横径的2DUS与CEUS差值鉴别乳腺癌与良性肿瘤:AUC 0.863(95%CI 0.785-0.942),敏感度0.667,特异度0.936,阈值0.203。

临床应用与阅片要点

  • 作者认为CEUS可能提供更精确的肿瘤大小评估,对确定最佳治疗策略和改善乳腺癌患者预后至关重要。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Ultrasound (US) imaging has been observed to underestimate tumor size in clinical practice. This study aims to compare the size measurements of breast cancer and benign tumors using two-dimensional ultrasound (2DUS) and contrast-enhanced ultrasound (CEUS).

METHODS: The study included 42 clinically confirmed breast cancer and 47 benign breast tumors. Two experienced physicians independently measured the maximal longitudinal and transverse diameters of the masses in 2DUS and CEUS. All analyses were performed in R (4.2.2) and GraphPad Prism 6.

RESULTS: The maximal longitudinal and transverse diameters of breast cancer measured by CEUS were 26.61 ± 0.21% and 26.24 ± 0.19% larger compared with 2DUS, and benign breast tumors had an 11.74 ± 0.21% and 11.06 ± 0.14% increase in size compared with 2DUS. The area under the curve (AUC) of the receiver operating characteristic curve (ROC) for the difference between 2DUS and CEUS was 0.870 for longitudinal diameters (95% CI: 0.795-0.945, sensitivity 0.842, specificity 0.783, threshold value 0.215), and 0.863 for transverse diameters (95% CI: 0.785-0.942, sensitivity 0.667, specificity 0.936, threshold value 0.203).

CONCLUSIONS: The size measurements of both breast cancer and benign tumors were larger in CEUS compared with 2DUS, with CEUS measurements of breast cancer being more pronounced than those of benign breast tumors. These findings suggest that CEUS may provide a more precise assessment of tumor size, which is crucial for determining optimal treatment strategies and improving patient outcomes in breast cancer management.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Tian Y, Wang W, Hu Y, et al. The Size Differences of Breast Cancer and Benign Tumors Measured by Two-Dimensional Ultrasound and Contrast-Enhanced Ultrasound. J Ultrasound Med. 2024. PMID: 38477076. doi:10.1002/jum.16449

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。